Lipid rafts, death receptors and CASMERs: new insights for cancer therapy

Author： Mollinedo Faustino Gajate Consuelo

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.4, 2010-04, pp. : 491-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian Cancer--New Insights into Systemic Therapy

By Neijt J.P.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 823-824

Elsevier

Access to resources Recommend Favorite

Proteomic profiling of lipid rafts in a human breast cancer model of tumorigenic progression

By Caruso Joseph

Clinical and Experimental Metastasis, Vol. 28, Iss. 6, 2011-08 ,pp. : 529-540

Springer Publishing Company

Access to resources Recommend Favorite

Redistribution of CD95 into the Lipid Rafts to Treat Cancer Cells?

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 22-28

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 274-283

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into the Role of Fc Gamma Receptors (Fc&ggr;Rs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite